Sumitomo Pharma America
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (131)
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Started: 1/28/2023
A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).
Started: 3/17/2022
A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
Started: 12/21/2021
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Started: 8/31/2015
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
Started: 12/1/2016
A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer
Started: 6/1/2016
A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer
Started: 10/1/2014
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Started: 12/8/2017
A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Started: 11/1/2016
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Started: 12/19/2018
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
Started: 6/18/2015
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder
Started: 3/31/2017
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Started: 7/31/2017
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Started: 4/30/2016
A Twelve Week, Open Label Extension Study in Patients With Schizophrenia
Started: 4/1/2012
A Pediatric Drug Study to Determine the Long-term Safety and Tolerability in Children and Adolescents (4-17 Years in Age) Taking the Drug
Started: 7/6/2017
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia
Started: 5/1/2009
Safety & Efficacy of Eslicarbazepine Monotherapy in Sub.w/Partial Epilepsy Not Well Controlled by Current Antiepileptic
Started: 6/1/2010
Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex
Started: 6/1/2011
This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Started: 6/1/2012
Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
Started: 9/1/2011
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
Started: 4/1/2009
A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
Started: 7/1/2014
Major Depressive Disorder With Mixed Features - Extension
Started: 9/1/2011
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis
Started: 11/1/2008
Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.
Started: 10/1/2008
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Started: 4/1/2009
Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
Started: 3/1/2008
A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder
Started: 8/1/2010
Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Started: 1/1/2008
Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia
Started: 12/1/2008
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
Started: 12/1/2008
Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis
Started: 7/1/2011
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
Started: 11/1/2011
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
Started: 10/1/2011
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
Started: 4/1/2009
Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
Started: 4/1/2009
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
Started: 11/1/2010
Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Started: 6/1/2009
Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
Started: 5/1/2009
Study To Evaluate Patient Preference, Satisfaction And Efficacy Of a Nasal Aerosol Versus an Aqueous Nasal Spray
Started: 7/1/2011
A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
Started: 6/1/2010
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
Started: 2/1/2011
Study of the Effects of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol on Hypothalamic-Pituitary-Adrenal (HPA) Axis
Started: 1/1/2010
A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Started: 2/1/2010
Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older
Started: 12/1/2009
A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older
Started: 8/1/2009
A Study of BBI503 in Asymptomatic Recurrent Ovarian Cancer Patients With CA-125 Elevation
Started: 6/1/2015
A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Started: 3/1/2012
A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer
Started: 2/1/2015
A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies
Started: 1/1/2017
A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Started: 3/13/2017
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
Started: 1/15/2020
A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression
Started: 6/26/2018
A Study That Compares the Extent to Which Apomorphine Becomes Available in the Body After Taking Either an Investigational Drug Containing Apomorphine or Apomorphine That is Injected Under the Skin in People With PD Complicated by "OFF" Episodes
Started: 8/22/2017
A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes
Started: 8/3/2017
A Study to Examine APL-130277 in Patients With Parkinson's Disease
Started: 8/31/2014
Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
Started: 1/1/2008
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
Started: 1/1/2008
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Started: 12/16/2019
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
Started: 4/16/2026
How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers
Started: 3/26/2026
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Started: 2/28/2022
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
Started: 12/18/2024
Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer
Started: 2/18/2021
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
Started: 12/26/2018
Assessment of Relative Bioavailability and Effect of Food on Capsule and Tablet Formulations of TP-3654
Started: 5/22/2023
A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Started: 6/1/2018
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
Started: 12/14/2017
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
Started: 8/1/2014
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Started: 4/1/2011
A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma
Started: 12/1/2014
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).
Started: 9/25/2017
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer
Started: 1/1/2014
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma
Started: 3/1/2015
A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers
Started: 8/1/2015
A Study of BBI503 in Adult Patients With Advanced Solid Tumors
Started: 2/1/2012
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers
Started: 6/30/2017
A Study of BBI608 in Adult Patients With Advanced Malignancies
Started: 3/1/2009
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Started: 5/1/2015
First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors
Started: 7/10/2018
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Started: 12/14/2016
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Started: 11/1/2015
Study of TP-3654 in Patients With Advanced Solid Tumors
Started: 4/16/2019
A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
Started: 9/1/2015
A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile
Started: 5/15/2018
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
Started: 6/10/2019
A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS
Started: 12/28/2020
A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
Started: 8/29/2018
A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors
Started: 4/1/2015
A Study to Evaluate the Mass Balance of 14C-Napabucasin in Healthy Adult Male Subjects
Started: 5/18/2018
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
Started: 2/24/2020
A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia
Started: 6/7/2018
Clinical Study of WT2725 in Patients With Advanced Malignancies
Started: 7/31/2012
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
Started: 5/1/2016
A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
Started: 12/1/2012
A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects
Started: 2/1/2012
Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy Adults
Started: 11/1/2009
A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler
Started: 6/1/2011
Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl
Started: 5/1/2009
Midazolam Drug-Drug Interaction Study With Lurasidone HCl
Started: 10/1/2008
The Bioequivalence Of Two Different Lurasidone Formulations In Patients
Started: 7/1/2008
Lithium Drug-Drug Interaction Study With Lurasidone HCl
Started: 8/1/2008
Rifampin Drug-Drug Interaction Study With Lurasidone HCl
Started: 8/1/2008
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures
Started: 7/7/2017
A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects
Started: 11/1/2014
A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
Started: 9/1/2012